Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

32.4K
Overview
32.4K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

3
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
3
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.5K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

1
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
1
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.2K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.2K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.5K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EAACI Guidelines on Environmental Science for Allergy and Asthma-Evidence-Based Recommendations for Prevention and Public Health Action to Mitigate the Impact of Pollen Exposure on Respiratory Allergy.

Allergy·2026
Same author

Meta-Analysis on the Harm of Systemic Glucocorticosteroids in Inflammatory Upper Airway Disease and Asthma: An EAACI Task Force.

Allergy·2026
Same author

Asthma endotypes and theratypes.

Chinese medical journal pulmonary and critical care medicine·2026
Same author

Iron Physiology and Its Impact on Atopic Diseases: An EAACI Taskforce Report.

Allergy·2026
Same author

Patterns and Clinical Efficacy of Biologics Switching in Patients With Severe Asthma: A Systematic Review and Meta-Analysis.

Allergy·2026
Same author

Risk and Protective Factors for Infection, Severe Disease, and Mortality in Epidemic Respiratory Viruses.

Allergy·2026
Same journal

Biosimilars in allergology: an outline in pediatric patients.

Current opinion in allergy and clinical immunology·2026
Same journal

The immunogenetic landscape of systemic lupus erythematosus.

Current opinion in allergy and clinical immunology·2026
Same journal

Circadian control of innate immunity: molecular mechanisms and implications for allergic disorders.

Current opinion in allergy and clinical immunology·2026
Same journal

Probiotics in allergic disease: from adjunct supplement to immune-modifying strategy (2026 update).

Current opinion in allergy and clinical immunology·2026
Same journal

Updates on drug-induced anaphylaxis in children.

Current opinion in allergy and clinical immunology·2026
Same journal

Beta-lactam de-labelling as a core antimicrobial stewardship strategy in the era of the antimicrobial resistance pandemic: a narrative review.

Current opinion in allergy and clinical immunology·2026
See all related articles

Related Experiment Video

Updated: Feb 13, 2026

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

2.6K

Endotypes in allergic diseases.

Ioana Agache1, Liliana Rogozea

  • 1Faculty of Medicine, Transylvania University, Brasov Romania.

Current Opinion in Allergy and Clinical Immunology
|March 22, 2018
PubMed
Summary
This summary is machine-generated.

Precision medicine for allergic diseases uses an endotype-driven approach to tailor treatments. This strategy identifies patient subgroups likely to benefit from specific therapies, improving outcomes and facilitating drug development.

More Related Videos

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

3.1K
Zebrafish Animal Model for the Study of Allergic Reactions in Response to Tick Saliva Biomolecules
07:01

Zebrafish Animal Model for the Study of Allergic Reactions in Response to Tick Saliva Biomolecules

Published on: September 16, 2022

2.2K

Related Experiment Videos

Last Updated: Feb 13, 2026

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

2.6K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

3.1K
Zebrafish Animal Model for the Study of Allergic Reactions in Response to Tick Saliva Biomolecules
07:01

Zebrafish Animal Model for the Study of Allergic Reactions in Response to Tick Saliva Biomolecules

Published on: September 16, 2022

2.2K

Area of Science:

  • Allergy and immunology
  • Precision medicine
  • Translational research

Background:

  • The concept of precision medicine offers promise but presents significant challenges in its application to allergic diseases.
  • Stratified medicine allows for the identification of patient subgroups who may benefit from specific therapies or experience adverse reactions.
  • This approach can predict long-term outcomes and vital risks, while also aiding in drug development and prevention strategies.

Purpose of the Study:

  • To review recent findings on the endotype-driven approach for major allergic diseases.
  • To highlight the potential and challenges of implementing precision medicine in allergy care.

Main Methods:

  • Review of recent scientific literature on endotype-driven approaches in allergic diseases.
  • Analysis of multidimensional endotyping strategies integrating clinical and biomarker data.
  • Assessment of barriers to implementing precision medicine in healthcare systems.

Main Results:

  • The endotype-driven approach has significant potential for personalized treatment of allergic diseases.
  • Multidimensional endotyping, encompassing both visible characteristics and biomarkers, is crucial for identifying key disease pathways in both type 2 and non-type 2 allergic conditions.
  • Barriers exist in achieving precision medicine goals, necessitating healthcare system adaptations.

Conclusions:

  • Implementing precision medicine in allergic diseases requires a shift towards endotype-driven strategies.
  • Multidimensional endotyping is essential for effective patient stratification and targeted therapy.
  • Significant healthcare system changes are necessary to realize the full potential of precision medicine in allergy.